Expertise Supporting FFC FFC
FUSION FUEL CYCLES INC. | MAY 2024 | 8
Ian Castillo
Head, Hydrogen & Tritium Technologies
Directorate, CNL
Dr. Castillo directs the R&D activities of CNL’s
Hydrogen and Tritium Directorate, aligning with
government stakeholder needs, market trends,
and leveraging CNL’s extensive hydrogen isotopes
expertise both nationally and internationally. With
over 17 years in the nuclear industry, he is an
expert in hydrogen production, recombination,
heavy water and tritium management, chemistry,
and process engineering. Dr. Castillo earned his
Ph.D. in Chemical Engineering from McGill
University.
Satoshi Konishi
Co-Founder, CEO & Chief Fusioneer
Kyoto Fusioneering Ltd.
Prof. Satoshi Konishi co-founded Kyoto
Fusioneering in 2019. With a Ph.D. in Engineering
from the University of Tokyo, Satoshi brings four
decades of expertise in R&D, specializing in fusion
technology, advanced nuclear system design, and
tritium engineering, including significant
contributions to the ITER project. He holds dual
roles as Chief Fusioneer, overseeing technology
development, strategic planning, and execution,
and as CEO, a position he has held since 2023.
Kiyoshi Seko
Director & COO
Kyoto Fusioneering Ltd.
Mr. Seko oversees business development,
fundraising, PR, and marketing from Kyoto
Fusioneering’s Tokyo office. With nearly a decade
at Mitsubishi Corporation, he facilitated several
international JVs and M&As. Seko's VC
experience at Coral Capital, investing in deeptech,
adds depth to his role. Holding degrees from
Kyoto University, University of Tokyo, and an MBA
from IE Business School, Spain, his interests span
reading, sports, and emerging technologies.
Stephen Bushby
Vice-President, Science & Technology
Canadian Nuclear Laboratories
Dr. Bushby is a senior nuclear executive with a
long and accomplished career, previously working
as the Chief Nuclear Officer at AIC Global
Holdings, where he identified and assessed
investment opportunities in small modular reactor
(SMR), clean energy and targeted radio therapy
technologies. Dr. Bushby spent much of his career
working at AECL in progressive leadership roles,
including serving as the Vice-President of Science,
Technology and Commercial Oversight.
Get in touch at
[email protected]
Executive and Business
Yuhei Nozoe
Senior Manager, Business Development
Kyoto Fusioneering Ltd.
Yuhei has a comprehensive background
in business development and M&A. Formerly with
Mitsui & Co., he led M&As and developed
business ranging from oil & gas, chemical, IT (AI,
Optimization, Digital Twin, etc). After MBA from IE
Business School, Spain, he established/operated
industrial IT startup as intrapreneur and provided
clients with consultancy business for growth of
SMBs and startups as his personal career.
Bibake Uppal
Head of Kyoto Fusioneering America
Kyoto Fusioneering America Ltd.
Bibake leads KF's North American expansion,
building partnerships and commercial ties to
accelerate the development and
commercialization of KF’s technology. He has a
wealth of experience in M&A and strategy
consulting in the ERI industry, and corporate
communications and government relations in the
Canadian public sector. An MBA and MSc.
graduate from IE Business School, Bibake is a
decisive, outcome-focused leader in the evolving
energy landscape.
Sam Suppiah
Technical Director, Hydrogen & Tritium
Canadian Nuclear Laboratories
Dr. Suppiah, with over 35 years' expertise,
drives hydrogen and tritium technology
advancements at CNL. Formerly with the British
Gas Corporation, he's an expert in Tritium
Technologies, Catalysis, and Energy Storage. He's
Canada's delegate for the GEN IV VHTR Hydrogen
Production Board and a CHFCA board member. A
regular at IAEA presentations, he holds a Ph.D. in
Chemical Engineering from the University of
Birmingham, UK.
Denys Elliot
Director, Business Development
Canadian Nuclear Laboratories
Denys Elliot is the Director of Business
Development for Advanced Reactors (AR) at CNL.
He is the primary liaison between CNL and AR
vendors for contract establishment and advancing
AR technologies. Additionally, Denys oversees
CNL’s Canadian Nuclear Research Initiative,
supporting collaborative AR research in Canada.
His expertise lies in contract formation with AR
developers throughout the commercialization
process.